These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 6688430)
1. Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. Hurst RE; Poon MC; Griffith MJ J Clin Invest; 1983 Sep; 72(3):1042-5. PubMed ID: 6688430 [TBL] [Abstract][Full Text] [Related]
2. Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II. Scully MF; Ellis V; Seno N; Kakkar VV Biochem J; 1988 Sep; 254(2):547-51. PubMed ID: 2902851 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms for the anticoagulant effect of heparin and related polysaccharides. Ofosu FA Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155 [TBL] [Abstract][Full Text] [Related]
4. Plasma anticoagulant mechanisms of heparin, heparan sulfate, and dermatan sulfate. Ofosu FA; Buchanan MR; Anvari N; Smith LM; Blajchman MA Ann N Y Acad Sci; 1989; 556():123-31. PubMed ID: 2525356 [TBL] [Abstract][Full Text] [Related]
5. Antithrombin activity of fucoidan. The interaction of fucoidan with heparin cofactor II, antithrombin III, and thrombin. Church FC; Meade JB; Treanor RE; Whinna HC J Biol Chem; 1989 Feb; 264(6):3618-23. PubMed ID: 2914965 [TBL] [Abstract][Full Text] [Related]
6. Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II. Yamagishi R; Koide T; Sakuragawa N FEBS Lett; 1987 Dec; 225(1-2):109-12. PubMed ID: 3691797 [TBL] [Abstract][Full Text] [Related]
7. Different glycoforms of human thrombomodulin. Their glycosaminoglycan-dependent modulatory effects on thrombin inactivation by heparin cofactor II and antithrombin III. Koyama T; Parkinson JF; Sié P; Bang NU; Müller-Berghaus G; Preissner KT Eur J Biochem; 1991 Jun; 198(3):563-70. PubMed ID: 1646716 [TBL] [Abstract][Full Text] [Related]
8. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Sie P; Ofosu F; Fernandez F; Buchanan MR; Petitou M; Boneu B Br J Haematol; 1986 Dec; 64(4):707-14. PubMed ID: 2432917 [TBL] [Abstract][Full Text] [Related]
9. Fibrin moderates the catalytic action of heparin but not that of dermatan sulfate on thrombin inhibition in human plasma. Okwusidi JI; Anvari N; Kulczycky M; Blajchman MA; Buchanan MR; Ofosu FA J Lab Clin Med; 1991 May; 117(5):359-64. PubMed ID: 2019790 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Liu L; Dewar L; Song Y; Kulczycky M; Blajchman MA; Fenton JW; Andrew M; Delorme M; Ginsberg J; Preissner KT Thromb Haemost; 1995 Mar; 73(3):405-12. PubMed ID: 7545318 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate. Sié P; Fernandez F; Caranobe C; Gabaig AM; Boneu B Thromb Res; 1984 Jul; 35(2):231-6. PubMed ID: 6206589 [No Abstract] [Full Text] [Related]
12. Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin. Shimotori T; Sakuragawa N Semin Thromb Hemost; 1990 Oct; 16 Suppl():71-6. PubMed ID: 1962909 [TBL] [Abstract][Full Text] [Related]
13. [The second cofactor of heparin]. Sie P Ann Biol Clin (Paris); 1987; 45(2):181-3. PubMed ID: 3619144 [TBL] [Abstract][Full Text] [Related]
14. Purification and biological property of heparin cofactor II: activation of heparin cofactor II and antithrombin III by dextran sulfate and various glycosaminoglycans. Yamagishi R; Niwa M; Kondo S; Sakuragawa N; Koide T Thromb Res; 1984 Dec; 36(6):633-42. PubMed ID: 6084876 [TBL] [Abstract][Full Text] [Related]
15. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma. Simmons RB; Newton GR; Doctor VM Eur J Drug Metab Pharmacokinet; 1995; 20(1):73-7. PubMed ID: 7588997 [TBL] [Abstract][Full Text] [Related]
17. Heparin cofactor II and other endogenous factors in the mediation of the antithrombotic and anticoagulant effects of heparin and dermatan sulfate. Ofosu FA; Fernandez F; Gauthier D; Buchanan MR Semin Thromb Hemost; 1985 Apr; 11(2):133-7. PubMed ID: 3898370 [No Abstract] [Full Text] [Related]
18. Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II. Sié P; Petitou M; Lormeau JC; Dupouy D; Boneu B; Choay J Biochim Biophys Acta; 1988 Aug; 966(2):188-95. PubMed ID: 3401503 [TBL] [Abstract][Full Text] [Related]
19. Dermatan sulfate and heparin can be fractionated by affinity for heparin cofactor II. Griffith MJ; Marbet GA Biochem Biophys Res Commun; 1983 Apr; 112(2):663-70. PubMed ID: 6687802 [TBL] [Abstract][Full Text] [Related]
20. Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin. Kim YS; Linhardt RJ Thromb Res; 1989 Jan; 53(1):55-71. PubMed ID: 2922702 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]